Literature DB >> 30344142

Sleep-related eating disorder with mirtazapine.

Dhanya Shinith1, Anand Mathilakath1, Da-In Kim2, Biren Patel2.   

Abstract

Sleep-related eating disorder (SRED) is classified within parasomnia and is characterised by recurrent episodes of abnormal, dysfunctional eating during sleep. This report describes a case of SRED in a 19-year-old woman admitted to the psychiatric ward with worsening anxiety, low mood and suicidal ideation. She was started on low-dose mirtazapine for mood stabilisation and, following an incremental increase to 30 mg, she developed nocturnal binge eating of which she retained only partial memory on waking. She developed adverse health consequences as a result of these recurrent episodes. The subject's symptoms were relieved rapidly following reduction of the dose of mirtazapine back to 15 mg. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  drugs: psychiatry; psychiatry; psychiatry (drugs and medicines); sleep disorders

Mesh:

Substances:

Year:  2018        PMID: 30344142      PMCID: PMC6202969          DOI: 10.1136/bcr-2018-224676

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Sleep-related eating disorder induced by olanzapine.

Authors:  Vincent Paquet; John Strul; Laurent Servais; Isidore Pelc; Pierre Fossion
Journal:  J Clin Psychiatry       Date:  2002-07       Impact factor: 4.384

2.  Sleep-related eating disorder induced by risperidone.

Authors:  Mong-Liang Lu; Winston W Shen
Journal:  J Clin Psychiatry       Date:  2004-02       Impact factor: 4.384

3.  Sleep-related eating disorder secondary to zolpidem.

Authors:  Hipólito Nzwalo; Ligia Ferreira; Rita Peralta; Carla Bentes
Journal:  BMJ Case Rep       Date:  2013-02-21

Review 4.  Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects.

Authors:  G L Stimmel; J A Dopheide; S M Stahl
Journal:  Pharmacotherapy       Date:  1997 Jan-Feb       Impact factor: 4.705

Review 5.  Classification of sleep disorders.

Authors:  Michael J Thorpy
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

6.  Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.

Authors:  Mercè Masana; Analía Bortolozzi; Francesc Artigas
Journal:  Int J Neuropsychopharmacol       Date:  2010-08-12       Impact factor: 5.176

7.  Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies.

Authors:  Mercè Masana; Anna Castañé; Noemí Santana; Analía Bortolozzi; Francesc Artigas
Journal:  Neuropharmacology       Date:  2012-05-28       Impact factor: 5.250

8.  Zolpidem induced Nocturnal Sleep-Related Eating Disorder (NSRED) in a male patient.

Authors:  Amit Dang; Gaurav Garg; Padmanabh V Rataboli
Journal:  Int J Eat Disord       Date:  2009-05       Impact factor: 4.861

9.  Quetiapine-induced sleep-related eating disorder-like behavior: a case series.

Authors:  Sadeka Tamanna; M Iftekhar Ullah; Chelle R Pope; Garland Holloman; Christian A Koch
Journal:  J Med Case Rep       Date:  2012-11-06

10.  Sleep-related eating disorder associated with mirtazapine.

Authors:  Jong-Hyun Jeong; Won-Myong Bahk
Journal:  J Clin Psychopharmacol       Date:  2014-12       Impact factor: 3.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.